CXCL10 and vitiligo: On the other hand, inhibition of CXCR3 was reported to prevent the CXCL10-induced melanocyte apoptosis and T cell infiltration in the skin, and blocking their receptor CXCR3 by CXCR3 antibodies led to repigmentation in mice with established vitiligo [53, 57].